Cencora Moves to Buy American Oncology Network in Up to $2.4 Billion Deal
The Cencora American Oncology Network acquisition is valued at up to $2.4 billion. What was disclosed, what was not, and what to watch.
Get the latest industry insights and trends in the pharmaceutical sector with Med Pharma News. Stay informed about groundbreaking research, regulatory updates, and market analysis.
The Cencora American Oncology Network acquisition is valued at up to $2.4 billion. What was disclosed, what was not, and what to watch.
Vaccine research ethics under scrutiny after a halted Guinea-Bissau newborn trial: consent, control arms, approvals and what regulators ask.
Healthcare company spin-offs are in focus as Abbott plans to separate nutrition by end-2027. How spin-offs work, and what to read in the filing.
Cell and gene therapy manufacturing India: what the Nucelion and VeGen Bio CRDMO deal covers, and what it leaves out, from marketing to the 2028 target.
MMR vaccination is rising as Pennsylvania measles reaches 1,317 cases: over 56,000 provider doses in September and 10,000 by state nurses.
Hospital EBITDA impact of India’s 30% cancer drug margin cap: the estimate, assumptions to question and key dates, 27 October and 9 November.
Indian hospital IPOs: Paras Health’s ₹1,450 crore issue, debt-repayment plan, anchor round and expansion, with risks and open questions.
OpenAI life sciences AI adds Orchestra Bio’s R&D coordination team. What Rosalind covers, what was not disclosed and what to watch.
Ebola outbreak Africa update: Nigeria confirms an imported case in Abuja, the fifth country affected. What WHO says and what is still unknown.